Durvalumab vs Pravastatin

Durvalumab vs Pravastatin: Overview

This comparison examines the pharmacological differences between Durvalumab and Pravastatin.

Mechanism of Action

Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.

Pravastatin: Competitive inhibitor of HMG-CoA reductase.

Pharmacokinetics

Half-life: Durvalumab — 17 days; Pravastatin — 1.8 hours.

Chemical Properties

Molecular Formula: Pravastatin — C23H36O7.

Molecular Weight: Pravastatin — 424.5280 g/mol.

Type: Durvalumab — Antibody; Pravastatin — Small molecule.